The medication administered in the stomach for the treatment of cerebral thrombosis is usually low molecular weight heparin. Consultation with a specialist is recommended for specific treatment options. The medicine administered in the stomach is injected subcutaneously, and low molecular weight heparin may be used in patients with cerebral thrombosis according to the needs of the specific condition to exert anticoagulant effects, such as for cardiogenic cerebral embolism, and to prevent the new onset or progression of thrombosis. Low molecular weight heparin may cause bleeding, petechiae, allergies and other adverse reactions, is contraindicated in patients with hypersensitivity to heparin, coagulation disorders, active peptic ulcers or bleeding. In addition, some cerebrovascular disease may have diabetes mellitus, it is possible that subcutaneous injection of insulin in the abdomen to manage blood glucose, may cause hypoglycemic adverse reactions. Consultation with a specialist is recommended for specific dosing regimens. The medication should be evaluated and administered by medical personnel, and care should be taken to test coagulation function and observe the occurrence of any adverse reactions after the administration of the medication.